Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS

v3.21.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Total Net Revenues $ 6,493,870 $ 11,982,196
Total Cost of Sales 3,608,557 7,004,994
Gross Profit 2,885,313 4,977,202
Operating Expenses:    
Research and development 1,177,282 1,737,385
Selling, general and administrative 4,754,783 5,155,092
Depreciation and amortization 58,853 66,082
Total Operating Expenses 5,990,918 6,958,559
Operating Loss (3,105,605) (1,981,357)
Other Expenses:    
Gain on sale of fixed assets 0 150
Interest expense, net (21,645) (53,289)
Total Other Income (Expense) (21,645) (53,139)
Loss before Provision for Income Taxes (3,127,250) (2,034,496)
Provision for Income Taxes 22,602 (100,363)
Net Loss Attributable to Common Stockholders $ (3,149,852) $ (1,934,133)
Net Loss per Common Share:    
Basic - net loss attributable to common stockholders $ (0.02) $ (0.01)
Diluted - net loss attributable to common stockholders $ (0.02) $ (0.01)
Weighted Average Common Shares Outstanding - basic 136,231,562 135,213,641
Weighted Average Common Shares Outstanding - diluted 136,231,562 135,213,641
Product [Member]    
Total Net Revenues $ 5,742,251 $ 11,212,854
Total Cost of Sales 3,527,977 6,703,494
Recurring [Member]    
Total Net Revenues 751,619 769,342
Total Cost of Sales $ 80,580 $ 301,500